E76.210
BillableMorquio A mucopolysaccharidoses
HCC Category Mapping
What This Code Means
Morquio A mucopolysaccharidosis is a rare inherited metabolic disorder characterized by severe skeletal deformities, short stature, and progressive joint and spine problems due to accumulation of complex sugars.
Coding Tips
- •Morquio A is the classic form; ensure you are not confusing it with Morquio B, which has different enzyme deficiency
- •Document associated complications such as cardiac valve disease, hearing loss, or vision problems for comprehensive coding
Clinical Significance
Morquio A mucopolysaccharidosis (MPS IVA) is caused by deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), leading to accumulation of keratan sulfate and chondroitin-6-sulfate. It primarily affects the skeleton with severe short stature, spinal cord compression risk, and joint laxity while preserving intelligence, making it distinct from many other MPS types.
Documentation Requirements
- ✓Specific diagnosis of Morquio A syndrome (MPS IVA) documented
- ✓Confirmatory enzyme assay showing GALNS deficiency or genetic testing with GALNS gene mutation
- ✓Skeletal manifestations: short trunk dwarfism, pectus carinatum, genu valgum, odontoid hypoplasia
- ✓Cervical spine stability assessment (risk of atlantoaxial subluxation/spinal cord compression)
- ✓Treatment plan including enzyme replacement therapy (elosulfase alfa/Vimizim), surgical interventions, or supportive care